Eli Lilly stock fell on Tuesday after Novo Nordisk, its rival in diabetes and weight-loss drugs, secured regulatory approval ...

Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than ...

Eli Lilly and Company (NYSE:LLY) is one of the Best Stocks to Invest in for the Next 3 Years. On December 12, Eli Lilly and ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks Jim Cramer answered questions about. Inquiring if their portfolio is ...

Lilly has already submitted the combination data for US regulatory review in ESR1-mutated metastatic breast cancer.

Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity ...

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Notably, the Huntsville site will be among those that will manufacture orforglipron, Lilly’s first oral, small molecule GLP-1 receptor agonist, which the company expects to submit to global regulatory ...

Eli Lilly & Company (LLY) discovers, develops & markets human pharmaceuticals worldwide. It comes under Healthcare sector & ...

Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook ...